Kineta (KANT, $0.51) was a top loser this month, diving -1 to $0.51 per share. Of the 861 stocks analyzed in the Biotechnology Industry throughout this month, of them (4) exhibited an Uptrend while of them (5) were in a Downtrend. A.I.dvisor found 492 similar cases when KANT's price dropped within one month. In out of those 492 cases, KANT's price continued to decline in the subsequent month. Based on this historical data, A.I. thinks the odds of a Downtrend continuation for KANT are